Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company DanPET AB
DescriptionNicotinic acetylcholine receptor alpha 6 (CHRNA6) agonist
Molecular Target Nicotinic acetylcholine receptor alpha 6 (CHRNA6)
Mechanism of ActionNicotinic acetylcholine receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat levodopa-induced dyskinesia in patients with Parkinson's disease (PD); Treat parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today